{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:11:17Z","timestamp":1790179877489,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Although the establishment, maintenance and reactivation from alphaherpesvirus latency is far from fully understood, some things are now manifestly clear: Alphaherpesvirus latency occurs in neurons of the peripheral nervous system and control of the process is multifactorial and complex. This includes components of the immune system, contributions from non-neuronal cells surrounding neurons in ganglia, specialized nucleic acids and modifications to the viral DNA to name some of the most important. Efficacious vaccines have been developed to control both acute varicella and zoster, the outcome of reactivation, but despite considerable effort vaccines for acute herpes simplex virus (HSV) infection or reactivated lesions have thus far failed to materialize despite considerable effort. Given the relevance of the immune system to establish and maintain HSV latency, a vaccine designed to tailor the HSV response to maximize the activity of components most critical for controlling reactivated infection might limit the severity of recurrences and hence reduce viral transmission. In this review, we discuss the current understanding of immunological factors that contribute to HSV and VZV latency, identify differences between varicella-zoster virus (VZV) and HSV that could explain why vaccines have been valuable at controlling VZV disease but not HSV, and finish by outlining possible strategies for developing effective HSV vaccines.<\/jats:p>","DOI":"10.3390\/v14050862","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T02:22:02Z","timestamp":1650766922000},"page":"862","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy"],"prefix":"10.3390","volume":"14","author":[{"given":"Barry T.","family":"Rouse","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Scott","family":"Schmid","sequence":"additional","affiliation":[{"name":"Independent Contract Consultant, Littleton, CO 80125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.aivir.2015.10.001","article-title":"Alphaherpesvirus Latency: A Dynamic State of Transcription and Reactivation","volume":"94","author":"Bloom","year":"2016","journal-title":"Adv. Virus Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-micro-092412-155654","article-title":"An Inquiry into the Molecular Basis of HSV Latency and Reactivation","volume":"67","author":"Roizman","year":"2013","journal-title":"Ann. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1172\/JCI136225","article-title":"Herpesvirus latency","volume":"130","author":"Cohen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_4","first-page":"99","article-title":"Reactivation from latency by alpha-herpesvirinae submfamily members: A stressful stimulation","volume":"12","author":"Jones","year":"2014","journal-title":"Curr. Top. Virol."},{"key":"ref_5","first-page":"229","article-title":"Molecular characterization of varicella zoster virus in latently infected human ganglia: Physical state and abundance of VZV DNA, quantitation of viral transcripts and detection of VZV-specific proteins","volume":"342","author":"Azarkh","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41467-018-03569-2","article-title":"A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61","volume":"9","author":"Depledge","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Braspenning, S., Lebbink, R.J., Depledge, D.P., Schapendonk, C.M.E., Anderson, L.A., Verjans, G.M.G.M., Sadaoka, T., and Ouwendijk, E.J.D. (2021). Mutagenesis of the varicella-zoster virus genome demonstrates that VLT and VLT-ORF63 proteins are dispensable for lytic infection. Viruses, 13.","DOI":"10.3390\/v13112289"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","article-title":"Pathogenesis and virulence of herpes simplex virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Virulence"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/sti.2006.019935","article-title":"Genital HSV-1 infections","volume":"82","author":"Wald","year":"2006","journal-title":"Sex. Trans. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"723809","DOI":"10.3389\/fimmu.2021.723809","article-title":"Local immune control of latent herpes simplex type 1 in ganglia of mice and man","volume":"12","author":"Koelle","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00439-020-02127-5","article-title":"Herpes simplex virus encephalitis of childhood: Inborn errors of central nervous system cell-intrinsic immunity","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/505496","article-title":"Management of Herpes Simplex Virus Type 2 Infection in HIV Type 1\u2013Infected Persons","volume":"43","author":"Strick","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Johnston, C., Magaret, A., Roychoudhury, P., Greninger, A.L., Reeves, D., Schiffer, J., Jerome, K.R., Sather, C., Diem, K., and Lingappa, J.R. (2017). Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002475"},{"key":"ref_15","first-page":"103","article-title":"Immune evasion by herpes simplex virus type 1, strategies for virus survival","volume":"114","author":"Friedman","year":"2003","journal-title":"Trans. Am. Clin. Clim. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus Infections in the Nervous System","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Miranda-Saksena, M., Denes, C.E., Diefenbach, R.J., and Cunningham, A.L. (2018). Infection and Transport of Herpes Simplex Virus Type 1 in Neurons: Role of the Cytoskeleton. Viruses, 10.","DOI":"10.3390\/v10020092"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01701-19","DOI":"10.1128\/JVI.01701-19","article-title":"Herpes simplex virus latency Is noisier the closer we look","volume":"94","author":"Singh","year":"2020","journal-title":"J. Virol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coi.2004.05.003","article-title":"Immune control of herpes simplex virus during latency","volume":"16","author":"Khanna","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/JVI.73.4.3418-3423.1999","article-title":"Role for Gamma Interferon in Control of Herpes Simplex Virus Type 1 Reactivation","volume":"73","author":"Cantin","year":"1999","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1128\/jvi.66.12.7336-7345.1992","article-title":"Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice","volume":"66","author":"Deshmane","year":"1992","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fonc.2018.00268","article-title":"Transgenic Mouse Models in Cancer Research","volume":"8","author":"Lampreht","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0192623316675767","article-title":"Translating Mouse Models: Immune Variation and Efficacy Testing","volume":"45","author":"Sellers","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/CVI.00318-08","article-title":"Role of Dendritic Cells in Enhancement of Herpes Simplex Virus Type 1 Latency and Reactivation in Vaccinated Mice","volume":"15","author":"Mott","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-017-0568-7","article-title":"Herpes Simplex Encephalitis: An Update","volume":"19","author":"Gnann","year":"2017","journal-title":"Curr. Infect. Dis Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). Monkey B virus. Human Herpesviruses Biology, Therapy, and Immunoprophylaxis, Cambridge University Press. [1st ed.].","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.4049\/jimmunol.2100453","article-title":"Inhibiting Glucose Metabolism Results in Herpes Simplex Encephalitis","volume":"207","author":"Berber","year":"2021","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature12110","article-title":"Immune surveillance by CD8\u03b1\u03b1+ skin-resident T cells in human herpes virus infection","volume":"497","author":"Zhu","year":"2013","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.20061792","article-title":"Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation","volume":"204","author":"Zhu","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_30","unstructured":"Zhu, J. Personal communication."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"735643","DOI":"10.3389\/fimmu.2021.735643","article-title":"Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"594963","DOI":"10.3389\/fimmu.2020.594963","article-title":"Virus Infections and Host Metabolism\u2014Can We Manage the Interactions?","volume":"11","author":"Sumbria","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_33","first-page":"211","article-title":"Experimental models to study varicella-zoster virus infection of neurons","volume":"342","author":"Steain","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/jmv.10325","article-title":"Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus","volume":"70","author":"Chen","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Messaoudi, I., Barron, A., Wellish, M., Engelmann, F., Legasse, A., Planer, S., Gilden, D., Nicolich-Zugich, J., and Mahalingam, R. (2009). Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella-zoster virus infection in humans. PLoS Pathog, 5.","DOI":"10.1371\/journal.ppat.1000657"},{"key":"ref_36","first-page":"255","article-title":"Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts","volume":"342","author":"Zerboni","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/JVI.03445-13","article-title":"Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia","volume":"88","author":"Steain","year":"2014","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1128\/JVI.01331-12","article-title":"Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death","volume":"86","author":"Ouwendijk","year":"2012","journal-title":"J. Virol."},{"key":"ref_39","first-page":"200","article-title":"Latency of varicella zoster virus; a persistently perplexing state","volume":"4","author":"Kinchington","year":"1999","journal-title":"Front. Biosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00123-20","DOI":"10.1128\/JVI.00123-20","article-title":"Varicella-zoster virus (VZV) small noncoding RNAs antisense to the VZV latency-encoded transcript VLT enhance viral replication","volume":"94","author":"Bisht","year":"2020","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/JVI.05950-11","article-title":"Apparent Expression of Varicella-Zoster Virus Proteins in Latency Resulting from Reactivity of Murine and Rabbit Antibodies with Human Blood Group A Determinants in Sensory Neurons","volume":"86","author":"Zerboni","year":"2012","journal-title":"J. Virol."},{"key":"ref_42","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jdermsci.2012.10.015","article-title":"Shozu Herpes Zoster Study. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain","volume":"69","author":"Asada","year":"2013","journal-title":"J. Derm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.DMIH2-0017-2015","article-title":"Herpes simplex virus and varicella-zoster virus","volume":"4","author":"Levin","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13365-015-0408-1","article-title":"Characterization of the immune response in ganglia after primary simian varicella virus infection","volume":"22","author":"Ouwendijk","year":"2016","journal-title":"J. Neurovirol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1128\/JVI.01272-16","article-title":"Acute Simian Varicella Virus infection causes robust and sustained changes in gene expression in the sensory ganglia","volume":"90","author":"Arnold","year":"2016","journal-title":"J. Virol."},{"key":"ref_47","first-page":"8861","article-title":"Characterization of the host immune response in human ganglia after herpes zoster","volume":"84","author":"Gowrishankar","year":"2010","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1073\/pnas.0501045102","article-title":"Varicella-zoster virus infection of human dorsal root ganglia in vivo","volume":"102","author":"Zerboni","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","first-page":"1181","article-title":"Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors","volume":"47","author":"Mitterreiter","year":"2017","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/JVI.01816-10","article-title":"Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection","volume":"85","author":"Steain","year":"2011","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s13365-017-0522-3","article-title":"Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus","volume":"23","author":"Arnold","year":"2017","journal-title":"J. Neurovirol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3389\/fmicb.2019.01634","article-title":"Modeling varicella zoster virus persistence and reactivation\u2014Closer to resolving a perplexing persistent state","volume":"10","author":"Laemmle","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13365-012-0123-0","article-title":"Human trigeminal ganglionic explants as a model to study alphaherpesvirus reactivation","volume":"18","author":"Azarkh","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Baird, N.L., Zhu, S., Pearce, K.M., and Veijo-Barbolla, A. (2019). Current in virto models to study varicella zoster virus latency and reactivation. Viruses, 11.","DOI":"10.3390\/v11020103"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lee, K.S., Zhou, W., Scott-MCKean, J.J., Emmerling, K.L., Cai, G., Krah, D.L., Costa, A.C., Freed, C.R., and Levin, M.J. (2012). Human sensory neurons derived from induced pluripotent stem cels support varicella-zoster virus infection. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0053010"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Markus, A., Lebenthal-Loinger, I., Yang, I.H., Kinchington, P.R., and Goldstein, R.S. (2015). An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004885"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e3108","DOI":"10.1038\/cddis.2017.504","article-title":"Current progress in the derivation and therapeutic application of neural stem cells","volume":"8","author":"Tang","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13365-012-0142-x","article-title":"Varicella zoster virus infection of highly pure terminally differentiated human neurons","volume":"19","author":"Yu","year":"2013","journal-title":"J. Neurovirol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/nm.2051","article-title":"Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency","volume":"15","author":"Liang","year":"2009","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00558-12","DOI":"10.1128\/mBio.00558-12","article-title":"A novel selective LSD1\/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency","volume":"4","author":"Liang","year":"2013","journal-title":"mBio"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: Global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"ref_62","first-page":"330","article-title":"Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition","volume":"66","author":"Keet","year":"1990","journal-title":"Genitourin. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2018.02.067","article-title":"Review of mathematical models of HSV-2 vaccination: Implications for vaccine development","volume":"37","author":"Spicknell","year":"2019","journal-title":"Vaccine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/OLQ.0b013e3181d3d023","article-title":"Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2","volume":"37","author":"Alsallaq","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kim, H.C., and Lee, H.K. (2020). Vaccines against genital herpes: Where are we?. Vaccines, 8.","DOI":"10.3390\/vaccines8030420"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of herpes simplex virus types 1 and 2\u2014United States, 1999\u20132010","volume":"209","author":"Bradley","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/SMJ.0000000000000062","article-title":"HSV-1 and HSV-2 seroprevalence in the United States among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)","volume":"107","author":"Schulte","year":"2014","journal-title":"South. Med. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20170968","DOI":"10.1098\/rsif.2017.0968","article-title":"Model-based estimation of superinfection prevalence from limited datasets","volume":"15","author":"Reeves","year":"2018","journal-title":"J. R Soc. Interface"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00908-17","DOI":"10.1128\/JVI.00908-17","article-title":"Impacts of genome-wide analyses on our understanding of human herpesvirus diversity and evolution","volume":"92","author":"Renner","year":"2017","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4049\/jimmunol.104.2.289","article-title":"A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans","volume":"104","author":"Douglas","year":"1970","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/iai.31.2.624-630.1981","article-title":"Immune response to herpes simplex virus infections: Virus-specific antibodies from patients with recurrent facial infections","volume":"31","author":"Zweerink","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: Implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_73","first-page":"1","article-title":"Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose Varicella Vaccine Effectiveness and Rash Severity in Outbreaks of Varicella Among Public School Students","volume":"33","author":"Thomas","year":"2014","journal-title":"Ped. Infect. Dis. J."},{"key":"ref_75","first-page":"189","article-title":"Varicella-zoster virus T cell tropism and the pathogenesis of skin infection","volume":"342","author":"Arvin","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"ZOE-50 Study Group. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/infdis\/jiy383","article-title":"Comparative immune responses to licensed herpes zoster vaccines","volume":"218","author":"Weinberg","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1016\/j.vaccine.2007.07.051","article-title":"Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine","volume":"25","author":"Levin","year":"2007","journal-title":"Vaccine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/21645515.2018.1560918","article-title":"Immune responses to zoster vaccines","volume":"15","author":"Levin","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e00240-21","DOI":"10.1128\/JVI.00240-21","article-title":"Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines","volume":"95","author":"Schmid","year":"2021","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.4049\/jimmunol.1501463","article-title":"IL-21 and IL-4 collaborate to shape T-dependent antibody responses","volume":"195","author":"McGuire","year":"2015","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"827256","DOI":"10.3389\/fimmu.2021.827256","article-title":"TLR signaling shapes and maintains antibody diversity upon virus-like particle immunization","volume":"12","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/862\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:58:22Z","timestamp":1760137102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14050862"],"URL":"https:\/\/doi.org\/10.3390\/v14050862","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]}}}